
Aerie Pharmaceuticals (AERI)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Aerie Pharmaceuticals (AERI) Stock
Start investing in Aerie Pharmaceuticals (AERI)
About Aerie Pharmaceuticals (AERI)
Market cap | $753.62M |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 1.53M |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | -19.89x |
Today's range | — |
Debt / equity | — |
52 week range | $4.81 - $15.37 |
5 year debt / equity | — |
Beta (LTM) | 0.9x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | Nov 3, 2022 |
Dividend payable date | — |
Aerie Pharmaceuticals Stock News
View all



Frequently Asked Questions (FAQ)
How to buy AERI stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in AERI stock
Navigate to the Explore page. Then, type AERI into the search bar. When you see AERI stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased AERI stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Aerie Pharmaceuticals Stock Earnings
The value each AERI share was expected to gain vs. the value that each AERI share actually gained.
Aerie Pharmaceuticals (AERI) reported Q3 2022 earnings per share (EPS) of -$0.27, beating estimates of -$0.44 by 38.64%. In the same quarter last year, Aerie Pharmaceuticals's earnings per share (EPS) was -$0.72. Aerie Pharmaceuticals is expected to release next earnings on 11/03/2022, with an earnings per share (EPS) estimate of $0.